| Dr Michael Poplawski, MD, PHD | |
|
2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 | |
| (856) 488-6500 | |
| (856) 922-5109 |
| Full Name | Dr Michael Poplawski |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 2201 Chapel Ave W, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831437789 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Specialists In Diagnostic Imaging Pa | 0244132124 | 17 |
| Jefferson University Radiology Associates Llc | 7315845708 | 91 |
| Jefferson University Physicians Of New Jersey Pc | 9931325131 | 104 |
| Rittenhouse Imaging Center Llc | 5193624583 | 27 |
| Jefferson University Radiology Associates Llc | 7315845708 | 91 |
| Jefferson University Physicians | 7911819180 | 1269 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
In New Jersey, advocates are making a case for the state to pursue this part of the health law, but Wisconsin's governor is pointing to its complexity as an argument against it. The Washington state legislature is also giving an expansion a long look.
The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.
› Verified 2 days ago
| Entity Name | Specialists In Diagnostic Imaging Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558347724 PECOS PAC ID: 0244132124 Enrollment ID: O20120404000080 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
In New Jersey, advocates are making a case for the state to pursue this part of the health law, but Wisconsin's governor is pointing to its complexity as an argument against it. The Washington state legislature is also giving an expansion a long look.
The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.
› Verified 2 days ago
| Entity Name | Jefferson University Physicians Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083039200 PECOS PAC ID: 9931325131 Enrollment ID: O20140724000727 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
In New Jersey, advocates are making a case for the state to pursue this part of the health law, but Wisconsin's governor is pointing to its complexity as an argument against it. The Washington state legislature is also giving an expansion a long look.
The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.
› Verified 2 days ago
| Entity Name | Garden State Radiology Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487056768 PECOS PAC ID: 3870815244 Enrollment ID: O20141215000979 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
In New Jersey, advocates are making a case for the state to pursue this part of the health law, but Wisconsin's governor is pointing to its complexity as an argument against it. The Washington state legislature is also giving an expansion a long look.
The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.
› Verified 2 days ago
| Entity Name | Jefferson University Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972169902 PECOS PAC ID: 7315845708 Enrollment ID: O20190924002409 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
In New Jersey, advocates are making a case for the state to pursue this part of the health law, but Wisconsin's governor is pointing to its complexity as an argument against it. The Washington state legislature is also giving an expansion a long look.
The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Poplawski, MD, PHD 2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 Ph: (856) 488-6500 | Dr Michael Poplawski, MD, PHD 2201 Chapel Ave W, Cherry Hill, NJ 08002-2048 Ph: (856) 488-6500 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2010.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
In New Jersey, advocates are making a case for the state to pursue this part of the health law, but Wisconsin's governor is pointing to its complexity as an argument against it. The Washington state legislature is also giving an expansion a long look.
The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.
› Verified 2 days ago
Vishal Desai, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-488-6500 Fax: 856-488-6507 | |
Eyal Barzel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 207 Kings Hwy S, #2, Cherry Hill, NJ 08034 Phone: 856-616-8600 Fax: 856-616-8601 | |
Chia-en Hsu, M.D. Radiology Medicare: May Accept Medicare Assignments Practice Location: 2201 Chapel Ave W, Radiology Department, Cherry Hill, NJ 08002 Phone: 856-488-6844 Fax: 856-488-6507 | |
Evan Rochlis, MD Radiology Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-922-4360 | |
Igor G Rayevsky, MD Radiology Medicare: Medicare Enrolled Practice Location: 1112 Winding Dr, Cherry Hill, NJ 08003 Phone: 856-429-0300 Fax: 856-429-0300 | |
Carol L Kornmehl, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2090 Springdale Rd Ste B, Cherry Hill, NJ 08003 Phone: 856-751-9010 | |
John Alaric Lentini, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 564-886-5008 Fax: 856-922-5109 |